-+ 0.00%
-+ 0.00%
-+ 0.00%

TriSalus wins FDA 510(k) clearance for TriNav Advance liver embolization device

PUBT·09/22/2026 20:15:22
Listen to the news
TriSalus wins FDA 510(k) clearance for TriNav Advance liver embolization device
  • Trisalus Life Sciences received FDA 510(k) clearance for TriNav Advance, expanding its Pressure-Enabled Drug Delivery device portfolio.
  • The device broadens access to smaller distal vessels, supporting a wider range of embolization procedures beyond liver-directed therapy.
  • A limited market release is planned over the coming weeks.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Trisalus Life Sciences Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 20260922558689) on September 22, 2026, and is solely responsible for the information contained therein.